Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases.
Our Operating Principles
Responsible capital allocation to ensure runway for maximum value creation
Continuous evaluation of portfolio based on data to make rapid go/no go decisions
Focus on rapid execution of priority programs with the highest probability of success
Seek strategic partnerships to maximize value generation